Agenus Inc news

   Watch this stock
Showing stories 1 - 10 of about 83   

Articles published

AGEN 3.26 +0.21 (6.89%)
price chart
Why Agenus Inc. Stock Briefly Spiked Higher
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Agenus (AGEN) Reports Positive Ph-2 Data from HerpV Study  StreetInsider.com (subscription)
Stocks Watch List � Microsoft Corporation, (NASDAQ:MSFT),Agenus, (NASDAQ ...  Techsonian (press release)
Related articles »  
Why Agenus Inc. Stock Skyrocketed
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
UPDATE 1-Agenus brain cancer vaccine doubles survival rate in study  Reuters
Agenus Brain Cancer Vaccine Shows Extended Survival in Phase 2 Final Data ...  Wall Street Journal
Related articles »  
Agenus Inc. (AGEN) Soars: Stock Adds 10.3% in Session
Agenus Inc. (AGEN - Snapshot Report) was a big mover last session, as the company saw its shares rise by over 10% on the day.
Geron Corp. (GERN) Jumps: Stock Moves 8.1% Higher - Tale of the Tape  NASDAQ
Related articles »  
Watch List - Rentech, Inc. (NASDAQ:RTK), Accuray (NASDAQ:ARAY), Agenus ...
Rentech, Inc. (NASDAQ:RTK) decreased -3.40% and closed at $2.27 in the last trading session with the overall traded volume of 799,011 shares, versus the average volume of 3.50 million shares.
Related articles »  
Agenus Inc. (AGEN) Buy Rating Reiterated at HC Wainwright
H.C. Wainwright reiterated a Buy rating on Agenus Inc. (NASDAQ: AGEN) with a price target of $6.00. Comments follow phase 2 Prophage data.
Wall Street Briefing: Agenus Inc (NASDAQ:AGEN), GoPro Inc (NASDAQ:GPRO ...
Boston, MA 07/02/2014 (wallstreetpr) - Agenus Inc (NASDAQ:AGEN) announced that its experimental drug for brain cancer showed impressive results in mid-stage study.
Biotech Significant Gain On News- Agenus Inc (NASDAQ:AGEN), Galena ...  eMarketsDaily
Micro-cap Active Movers: Amicus Therapeutics, (NASDAQ:FOLD), Agenus Inc ...  Gaining Green
Related articles »  
Melting Stocks- Agenus Inc (AGEN), Knightsbridge Tankers Limited (NASDAQ ...
Birmingham, West Midlands - (TechSonian) - 9th July 2014 - Agenus Inc (NASDAQ:AGEN) is a biopharmaceutical company, is developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines, ...
Agenus Downgraded by Zacks to �Neutral� (AGEN)  WKRB News
Related articles »  
Healthcare Decliners: Array Biopharma Inc (NASDAQ:ARRY), Agenus Inc ...
On 16 JUNE Array Biopharma Inc (NASDAQ:ARRY) said it will present at the Wells Fargo Securities 2014 Healthcare Conference in Boston.
Microcap Losers: Rubicon Technology (NASDAQ:RBCN), Provectus ...  Crazy Joys
Health Industry In Highlight : NASDAQ:ACRX, NASDAQ:AGEN, NASDAQ:ARRY ...  Mesh Press (press release)
Related articles »  
How Bulls Walk in Biotech Industry- Agenus Inc (NASDAQ:AGEN), Arrowhead ...
Agenus Inc (NASDAQ:AGEN) [Trend Analysis] declared that its experimental cancer vaccine helped brain tumor patients live around twice as long compared by means of those who got standard of care treatment.
Related articles »  
Stocks to Keep Your Eyes on - Agenus Inc (AGEN), Neuralstem, Inc. (CUR ...
Las Vegas, NV - July 01, 2013 - (TechSonian) - Agenus Inc (NASDAQ:AGEN) declared promising Phase 2 results for HerpV, a synthetic vaccine candidate for the treatment of patients with genital Herpes Simplex Virus-2 (HSV-2).
Agenus Given "Buy" Rating at HC Wainwright (AGEN)  WKRB News
Microcap Bearish Stocks: Ixia (NASDAQ:XXIA), Mitek Systems (NASDAQ:MITK ...  Gaining Green
Related articles »